483 related articles for article (PubMed ID: 29455549)
21. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
[TBL] [Abstract][Full Text] [Related]
22. [Multiple endocrine neoplasia type 2A in a family].
Hircsu I; Gazdag A; Bodor M; Berta E; Andrási M; Kanyári Z; Győry F; Barna S; Bhattoa HP; Nagy B; Nagy VE; Erdei A
Orv Hetil; 2020 Jan; 161(2):75-79. PubMed ID: 31902232
[TBL] [Abstract][Full Text] [Related]
23. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
[TBL] [Abstract][Full Text] [Related]
24. High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene.
Toledo RA; Wagner SM; Coutinho FL; Lourenço DM; Azevedo JA; Longuini VC; Reis MT; Siqueira SA; Lucon AM; Tavares MR; Fragoso MC; Pereira AA; Dahia PL; Mulligan LM; Toledo SP
J Clin Endocrinol Metab; 2010 Mar; 95(3):1318-27. PubMed ID: 20080836
[TBL] [Abstract][Full Text] [Related]
25. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV
Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
[TBL] [Abstract][Full Text] [Related]
26. A rare extracellular D631Y germline mutation of the RET proto-oncogene in two Korean families with multiple endocrine neoplasia 2A.
Bae SJ; Kim DJ; Kim JY; Park SY; Choi SH; Song YD; Ki CS; Chung JH
Thyroid; 2006 Jun; 16(6):609-14. PubMed ID: 16839264
[TBL] [Abstract][Full Text] [Related]
27. Indolent medullary thyroid cancer with a RET proto-oncogene Cys618Phe mutation presenting as sporadic unilateral pheochromocytoma in a 55-year-old Korean woman.
Kim DD; Croxson MS; Cranshaw IM; Evans JL; Marquis-Nicholson R; Love DR
Thyroid; 2011 Mar; 21(3):325-6. PubMed ID: 21254918
[No Abstract] [Full Text] [Related]
28. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
[TBL] [Abstract][Full Text] [Related]
29. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
[TBL] [Abstract][Full Text] [Related]
30. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.
Recasens M; Oriola J; Fernández-Real JM; Roig J; Rodríguez-Hermosa JI; Font JA; Galofre P; López-Bermejo A; Ricart W
Clin Endocrinol (Oxf); 2007 Jul; 67(1):29-33. PubMed ID: 17466010
[TBL] [Abstract][Full Text] [Related]
31. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
Ospina NS; Maraka S; Donegan D; Morris JC
Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic adrenalectomy as an effective approach to massive bilateral pheochromocytomas.
Martins D; Rodrigues D; Melo M; Carrilho F
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28883010
[TBL] [Abstract][Full Text] [Related]
33. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.
Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Uchino S; Kosugi S; Kurahashi H; Iwase K
Surg Today; 2014 Nov; 44(11):2195-200. PubMed ID: 24449023
[TBL] [Abstract][Full Text] [Related]
34. Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome.
Lendvai N; Tóth M; Valkusz Z; Bekő G; Szücs N; Csajbók E; Igaz P; Kriszt B; Kovács B; Rácz K; Patócs A
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):85-9. PubMed ID: 22584711
[TBL] [Abstract][Full Text] [Related]
35. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.
Asari R; Scheuba C; Kaczirek K; Niederle B
Arch Surg; 2006 Dec; 141(12):1199-205; discussion 1205. PubMed ID: 17178962
[TBL] [Abstract][Full Text] [Related]
36. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.
Sarathi V; Bandgar TR; Menon PS; Shah NS
Gynecol Endocrinol; 2011 Aug; 27(8):533-5. PubMed ID: 20672905
[TBL] [Abstract][Full Text] [Related]
37. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis.
Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Kurahashi H; Iwase K
Endocr J; 2014; 61(1):19-23. PubMed ID: 24152999
[TBL] [Abstract][Full Text] [Related]
38. A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma.
Nunes AB; Ezabella MC; Pereira AC; Krieger JE; Toledo SP
J Clin Endocrinol Metab; 2002 Dec; 87(12):5658-61. PubMed ID: 12466368
[TBL] [Abstract][Full Text] [Related]
39. Germline mutations of the RET proto-oncogene in pedigree with MEN type 2A: DNA analysis and its implications for pediatric surgery.
Shimotake T; Iwai N; Inoue K; Inazawa J; Nishisho I
J Pediatr Surg; 1996 Jun; 31(6):779-81. PubMed ID: 8783101
[TBL] [Abstract][Full Text] [Related]
40. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Panayiotides IG; Economopoulos T; Raptis SA; Hadjidakis D
Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
